Otsuka (OTSKY) Stock Price, News & Analysis

Company Overview

Otsuka Holdings Co., Ltd. (OTCMKTS: OTSKY) is a global healthcare company headquartered in Tokyo, Japan, with operations spanning pharmaceuticals, nutraceuticals and consumer products. Founded in 1921, Otsuka has grown from a domestic manufacturer of tonics and over-the-counter remedies into a diversified enterprise focused on innovative therapies and wellness solutions. The company employs a network of research facilities, production sites and sales offices across Asia, North America, Europe and other regions, supporting a broad portfolio of products and services.

In the pharmaceutical sector, Otsuka is best known for developing and marketing treatments for central nervous system disorders, nephrology and oncology. Flagship products include Abilify (aripiprazole), one of the world’s leading antipsychotic medications, and Samsca (tolvaptan), used to manage hyponatremia and autosomal dominant polycystic kidney disease. In addition to small-molecule drugs, the company is advancing biologics, digital therapeutics and targeted cancer therapies through collaborations with academic institutions and biotech partners.

Otsuka’s nutraceutical division offers a range of specialty nutritional products designed to support health and well-being. Key offerings include the Pocari Sweat electrolyte drink, Calorie Mate balanced nutrition bars and SoyJoy snack bars, which are marketed in over 20 countries. The company also operates Otsuka Pharmaceutical Factory, which focuses on contract manufacturing and packaging services, and Otsuka America Pharmaceutical, which handles US-based research, regulatory affairs and commercialization efforts.

Under the leadership of President and CEO Yoshihito Ishizuka, Otsuka has emphasized innovation, sustainability and patient-centric care. The company continues to invest heavily in research and development, seeking breakthroughs in neurology, nephrology and oncology while exploring new modalities such as digital health platforms. With a commitment to corporate social responsibility, Otsuka endeavors to address unmet medical needs and contribute to global health through both established products and emerging therapies.

Key Stats

• Today's Range: $21.70 to $22.30
• 50-Day Range: $22.04 to $25.78
• 52-Week Range: $21.64 to $32.41
• Volume: 84,748 shs
• Average Volume: 50,857 shs
• Market Capitalization: $23.50 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OTSKY Stock Analysis - Frequently Asked Questions

How have OTSKY shares performed this year?

Otsuka's stock was trading at $27.18 at the beginning of 2025. Since then, OTSKY stock has decreased by 19.5% and is now trading at $21.88.

How do I buy shares of Otsuka?

Shares of OTSKY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/18/2025
• Next Earnings (Estimated): 7/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:OTSKY
• Previous Symbol: OTCMKTS:OTSKY
• CIK: 1544613
• Web: www.otsuka.com
• Phone: (136) 717-1410
• Fax: N/A
• Employees: 34,388
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.15
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,074,190,000
• Free Float: N/A
• Market Cap: $23.80 billion
• Optionable: Not Optionable
• Beta: N/A